Dr. Ellen Marmur Joins MedSpa Partners
TORONTO, May 12, 2025 /CNW/ - MedSpa Partners Inc. (" MSP") is proud to welcome Dr. Ellen Marmur and her team at Marmur Medical to its top-tier North American medical aesthetics platform. With two locations in Manhattan's Upper East Side, Marmur Medical has been providing world-class cosmetic and medical dermatology care to patients for nearly fifteen years.
Dr. Marmur is consistently recognized by leading publications and professional organizations as one of the top dermatologists in the United States. While her path—from leading wilderness survival canoe trips with a joint degree in Philosophy and Japanese to becoming one of the most renowned clinical and aesthetic dermatologists in America—may have been exceptional, it's emblematic of the breadth of drive, inspiration and expertise she brings to her pioneering approach. Her signature treatment philosophy, Preservation Aging®, focuses on supporting the body's natural healing systems to maintain healthy skin and overall wellbeing.
In addition to leading her thriving practice, Dr. Marmur is a serial entrepreneur and philanthropist. She is the founder of MMSkincare, an LED-activated, science-based skincare line and medical device company. She also established the non-profit Skin Cancer, Take a Hike!, which funds education and early detection programs for skin cancer—merging her passions for skin health and outdoor adventure.
Speaking on her reasons for joining MedSpa Partners, Dr. Marmur shared, "As a lifelong learner, I'm energized by people and organizations who push boundaries while staying grounded in what truly matters: the patient. MSP stood out because they treat their partners like people, not just another number. This isn't consolidation—it's collaboration. It's rare to find a growth partner that shares both your ambition and your integrity—MSP is that partner."
MSP CEO Dominic Mazzone commented, "We're honored to welcome Dr. Ellen Marmur and her incredible team at Marmur Medical to the MSP family. Ellen's reputation speaks for itself—she's a trailblazer in dermatology and a passionate educator, and it's been a pleasure to connect with her as kindred spirits as entrepreneurs. The care that Ellen and her team provide fits perfectly into MSP's goal of providing Michelin Star patient experiences. This partnership not only strengthens our presence in the Northeast, it also deepens our bench of industry leaders who share our values. Dr. Marmur's addition sets the tone for what promises to be another landmark year of growth, leadership, and partnership at MSP."
About MedSpa Partners Inc.
MedSpa Partners is acquiring North America's leading Medical Aesthetics clinics, with the goal of allowing our industry-leading partners to achieve their personal and professional aspirations by creating world-class customer experiences through support, collaboration, and community. MSP is a portfolio company of Persistence Capital Partners, the leading private equity fund exclusively focused on high-growth opportunities in the healthcare field. Additional information on MSP is available at www.medspapartners.com, or contact:
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Sun
a day ago
- Toronto Sun
Canada weighs retaliation cost against Trump tariffs as analysts warn hitting back isn't worth it
Published Aug 02, 2025 • Last updated 10 minutes ago • 4 minute read Tractor trailers entering the U.S. from Canada at the Pacific Highway Border Crossing in Blaine, Washington, on Monday, March 3, 2025. Photo by David Ryder / Bloomberg Canada's decision to retaliate against U.S. tariffs earlier this year appears to be driving a divergence in how President Donald Trump is dealing with America's neighbours. This advertisement has not loaded yet, but your article continues below. THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. SUBSCRIBE TO UNLOCK MORE ARTICLES Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. REGISTER / SIGN IN TO UNLOCK MORE ARTICLES Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account. Share your thoughts and join the conversation in the comments. Enjoy additional articles per month. Get email updates from your favourite authors. THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK. Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account Share your thoughts and join the conversation in the comments Enjoy additional articles per month Get email updates from your favourite authors Don't have an account? Create Account Until this week, Canada and Mexico received similar treatment in White House trade actions. Each was subject to a 25% base tariff, with a large exemption for goods shipped under the North American free trade pact known as CUSMA (or USMCA). That changed on Thursday, when Trump granted Mexico a 90-day pause on tariff hikes while jacking up its tax on Canadian products to 35%. The administration said Canada's higher rate was a response to fentanyl trafficking and its moves to hit back with counter-tariffs. The situation leaves Prime Minister Mark Carney with a political dilemma. On one hand, he won an election by promising a muscular approach to the trade war, saying the government would use tariffs to cause 'maximum pain' in the US. His voters remember that, and some want him to punch back. This advertisement has not loaded yet, but your article continues below. Yet the retaliatory measures already undertaken failed to prevent further escalations. Instead, they appear to have emboldened Trump's team to hit even harder. U.S. administration officials including Commerce Secretary Howard Lutnick frequently talk about how only two countries retaliated against Trump's tariffs — the other was China. 'Canada's retaliatory trade measures against the United States further complicate bilateral efforts to address this escalating drug crisis,' the White House said in a fact sheet, referencing fentanyl. But Mexico is a much larger source of shipments of the drug into the U.S., according to Customs and Border Protection data. Carney, an economist and former central banker, has also made it plain he believes retaliation can only go so far. In fact, his government has watered down Canada's counter-tariffs with a number of exemptions, declined to increase them when the U.S. lifted steel and aluminum tariffs to 50% and scrapped a tax on technology services at Trump's request. Your noon-hour look at what's happening in Toronto and beyond. By signing up you consent to receive the above newsletter from Postmedia Network Inc. Please try again This advertisement has not loaded yet, but your article continues below. Dominic LeBlanc, the minister in charge of trade talks, told Radio-Canada on Friday the government hasn't made any decisions about further retaliation. But Carney is clearly reluctant to do so — which 'reflects the reality that counter-tariffs are understood to be economically harmful to the country which imposes them,' said David Collins, a professor specializing in international trade at City St George's, University of London. The government's priority is to keep the CUSMA carve-out that dramatically lowers the real tax on Canadian goods. The effective U.S. tariff rate on Canada is about 6.3%, according to Bank of Nova Scotia economists. 'A more diplomatic approach is likely to bear more fruit with the Americans,' Collins said. This advertisement has not loaded yet, but your article continues below. Canada imposed two rounds of counter-tariffs in March, when Justin Trudeau was in his final days as prime minister. The first placed 25% levies on about $30 billion of imports from the U.S. that included food items, clothing and motorcycles. The second came when Trump put tariffs on steel and aluminum. Then, when Trump added tariffs to foreign automobiles, Carney essentially matched that move, imposing similar fees on U.S. cars and trucks. But in mid-April, the government unveiled a series of exemptions for business inputs — goods imported for use in manufacturing and food packaging, as well as things needed for health care, public safety and security. Automakers such as General Motors Co. and Honda Motor Co. that make vehicles at Canadian plants were also made eligible for relief from import taxes. This advertisement has not loaded yet, but your article continues below. The large majority of U.S. products can still enter Canada tariff-free. U.S. companies and other entities exported about $440 billion of goods and services to Canada last year — more than to any other nation. For Canada, 'the logic for escalation over cooperation is just weak,' said Oliver Lavelle, global macro strategist at Thiel Macro LLC. Mexico's Way Mexican President Claudia Sheinbaum, in contrast, has never imposed counter-tariffs on the U.S. Sheinbaum's position is also supported by her high approval ratings, which have remained above 75% in most polls. 'It's worth saying: President Trump treats us with respect in all the calls we've had, and we do too,' she said during a new conference. 'We may not agree, but the treatment is respectful.' This advertisement has not loaded yet, but your article continues below. A statement issued late Thursday night by Carney's office expressed disappointment in Trump's tariff hike on Canada, but made no mention of retaliation. A spokesperson for Carney declined to comment further. LeBlanc said he met with Lutnick on Tuesday night, and that Canadian officials held other meetings throughout the week, but a deal acceptable to both sides 'was not yet visible.' In his statement, Carney acknowledged that lumber, steel, aluminum and autos are still subject to U.S. levies, and said his government 'will act to protect Canadian jobs, invest in our industrial competitiveness, buy Canadian, and diversify its export markets.' 'Jitters' But while the CUSMA exemption gives Canada some breathing room, the sectoral tariffs on steel and aluminum are still harmful and will affect economic growth if they're in place for long, Collins said. This advertisement has not loaded yet, but your article continues below. Avery Shenfeld, chief economist at Canadian Imperial Bank of Commerce, said the idea that Canada is getting off lightly is 'both overstated and potentially premature.' Canadian industries are more reliant on U.S. exports than their overseas competitors, and Trump could also chose to weaken the CUSMA exemption at any time, he said in a note to investors. 'We are still hopeful for a deal that relieves at least some of the pressure on base metal exporters,' Shenfeld said. 'But whether any of this lasts will depend on Trump's word, and we've seen how shaky that foundation can be, leaving jitters that could impact business capital spending and confidence ahead.' —With assistance from Mario Baker Ramirez and Carolina Millan. Read More Toronto Blue Jays Columnists Columnists Toronto & GTA Canada
Vancouver Sun
a day ago
- Vancouver Sun
Why more fentanyl production could be moving to Canada
Although there's no evidence of any significant flows of fentanyl into the United States from Canada, an American authority on 'criminal supply chains' warned Friday that that could change abruptly if U.S. efforts to better seal its border with Mexico are successful. Jonathan Caulkins, who researches supply chains that support illegal markets for the Manhattan Institute think tank and Carnegie Mellon University. said the drug cartels that control the North American fentanyl trade may well shift large chunks of their operations to Canada if the northern border becomes the path of least resistance. Caulkins, the co-author behind a recent Manhattan Institute study of fentanyl supply chains , said the cartels are sophisticated, mobile and will adjust quickly if their cross-border routes are choked. Start your day with a roundup of B.C.-focused news and opinion. By signing up you consent to receive the above newsletter from Postmedia Network Inc. A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of Sunrise will soon be in your inbox. Please try again Interested in more newsletters? Browse here. 'They're not trying (now), but they sure could,' he said in an interview hours after U.S. President Donald Trump signed an executive order to increase tariffs on some Canadian exports (those products that aren't captured by the Canada-U.S.-Mexico free trade agreement) to the U.S. to 35 per cent from 25 per cent. Those tariffs, which kicked in earlier Friday, were necessary, according to Trump, because Canada has failed to co-operate with U.S. efforts to curb 'the ongoing flood of fentanyl and other illicit drugs.' Candace Laing, chief executive of the Canadian Chamber of Commerce, said Trump's fact sheet on the tariffs should be called a 'fact-less sheet' when it comes to using fentanyl as a justification for trade decisions about Canada. 'More fact-less tariff turbulence does not advance North American economic security,' she said. In the Manhattan Institute study, Caulkins and colleague Bishu Giri found that the vast majority of the fentanyl entering the U.S. from within North America is coming from Mexico, not Canada. They used new data from 2023–24 to show that about 40 per cent of the large seizures of fentanyl in the U.S. occurred in counties along the Mexican border, while just 1.2 per cent of the fentanyl powder and 0.5 per cent of pills along the Canadian border. To effectively combat the problem, the researchers wrote, law enforcement and legislators need to begin with accurate information. Caulkins said that fentanyl producers in Mexico and Canada are different in that the Canadian operations tend to produce opioids from imports that are nearly completely assembled with just the finishing ingredients added here, while the cartels in Mexico assemble all the ingredients to make opioids in that country to export to the U.S. In both cases, he said, the imports are believed to come mostly from China, although India may also be a source. Since Trump first raised the allegation earlier this year about fentanyl 'pouring' into the U.S. from its northern neighbour, Canada has taken a number of steps to combat the flow of illegal drugs, and to be seen to be doing so, into the U.S. The steps included: reinforcing the Canada-U.S. border with additional technology, helicopters and personnel; allocating $78.7 million to expand Health Canada's regulatory capabilities; increasing co-ordination with American law enforcement counterparts; hiring a fentanyl 'czar'; and launching consultations on improving crackdowns, as well as tabling Bill C-2, the Strong Borders Act to give Ottawa more law-enforcement powers. Kevin Brosseau, the fentanyl czar, was not made available for an interview this week, but in an interim report released in June he pointed out that U.S. Customs and Border Patrol data show that only 0.1 per cent of fentanyl seizures at U.S. borders are at the Canada-U.S. border, far less than the flow of illegal narcotics into Canada from the U.S. One thing that the players in the fight against illicit drugs seem to agree on is that the problem requires a multi-faceted response that addresses the border, legislative changes, money laundering and other financial angles, and enforcement that targets both precursors and fentanyl itself. The RCMP also declined an interview this week, but stated in an email that it intends to hit organized crime 'harder and faster' and that one of its priorities is to work with industry to prevent the diversion of precursors that are used to make fentanyl. Jamie Tronnes, executive director for the Center for North American Prosperity and Security, the U.S.-based office of the Macdonald-Laurier Institute, said Canada seems to be doing a good job of cracking down on the fentanyl trade, and ensuring that those efforts are seen by Trump and others in the White House. 'I believe that Canada is doing everything it can to demonstrate it's taking it seriously,' Tronnes said. She said Canada could focus more, however, on money laundering and other international financial crimes. Darren Gibb, head of communications at the Financial Transactions and Report Analysis Centre (FINTRAC), which works with police and financial institutions to target crimes such as money laundering and terrorist financing, said hiding profits from illegal activities such as fentanyl production isn't easy. 'It's their Achilles' heel,' he said of the drug cartels. National Post stuck@ Our website is the place for the latest breaking news, exclusive scoops, longreads and provocative commentary. Please bookmark and sign up for our daily newsletter, Posted, here .
Edmonton Journal
a day ago
- Edmonton Journal
Why more fentanyl production could be moving to Canada
Although there's no evidence of any significant flows of fentanyl into the United States from Canada, an American authority on 'criminal supply chains' warned Friday that that could change abruptly if U.S. efforts to better seal its border with Mexico are successful. Article content Jonathan Caulkins, who researches supply chains that support illegal markets for the Manhattan Institute think tank and Carnegie Mellon University. said the drug cartels that control the North American fentanyl trade may well shift large chunks of their operations to Canada if the northern border becomes the path of least resistance. Article content Article content Caulkins, the co-author behind a recent Manhattan Institute study of fentanyl supply chains, said the cartels are sophisticated, mobile and will adjust quickly if their cross-border routes are choked. Article content Article content 'They're not trying (now), but they sure could,' he said in an interview hours after U.S. President Donald Trump signed an executive order to increase tariffs on some Canadian exports (those products that aren't captured by the Canada-U.S.-Mexico free trade agreement) to the U.S. to 35 per cent from 25 per cent. Those tariffs, which kicked in earlier Friday, were necessary, according to Trump, because Canada has failed to co-operate with U.S. efforts to curb 'the ongoing flood of fentanyl and other illicit drugs.' Article content Candace Laing, chief executive of the Canadian Chamber of Commerce, said Trump's fact sheet on the tariffs should be called a 'fact-less sheet' when it comes to using fentanyl as a justification for trade decisions about Canada. 'More fact-less tariff turbulence does not advance North American economic security,' she said. Article content Article content In the Manhattan Institute study, Caulkins and colleague Bishu Giri found that the vast majority of the fentanyl entering the U.S. from within North America is coming from Mexico, not Canada. Article content Article content They used new data from 2023–24 to show that about 40 per cent of the large seizures of fentanyl in the U.S. occurred in counties along the Mexican border, while just 1.2 per cent of the fentanyl powder and 0.5 per cent of pills along the Canadian border. Article content To effectively combat the problem, the researchers wrote, law enforcement and legislators need to begin with accurate information. Caulkins said that fentanyl producers in Mexico and Canada are different in that the Canadian operations tend to produce opioids from imports that are nearly completely assembled with just the finishing ingredients added here, while the cartels in Mexico assemble all the ingredients to make opioids in that country to export to the U.S.
